Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 1
2019 2
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain.
Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MÁ, Menchén L. Taxonera C, et al. Among authors: lopez ibanez de aldecoa a. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):73-83. doi: 10.1080/14737167.2021.1880324. Epub 2021 Feb 20. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33615953
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain.
Formiga F, García-Pavía P, Martín Sánchez FJ, Navarro-Ruiz A, Rubio-Terrés C, Peral C, Tarilonte P, López-Ibáñez de Aldecoa A, Rubio-Rodríguez D. Formiga F, et al. Among authors: lopez ibanez de aldecoa a. Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1127-1133. doi: 10.1080/14737167.2021.1933948. Epub 2021 Jun 11. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 34047214 Free article.
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
Azanza JR, Grau S, Vázquez L, Rebollo P, Peral C, López-Ibáñez de Aldecoa A, López-Gómez V. Azanza JR, et al. Among authors: lopez ibanez de aldecoa a. Mycoses. 2021 Jan;64(1):66-77. doi: 10.1111/myc.13189. Epub 2020 Oct 30. Mycoses. 2021. PMID: 32989796 Free PMC article.